Reaction
Blood Lactate Dehydrogenase Decreased reporting signals
As of the last recalculation, Blood Lactate Dehydrogenase Decreased appears in 332 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is ECULIZUMAB (PRR 89.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Eculizumab | 63 | 89.5 | 89.6 |
| Anakinra | 13 | 51.1 | 51.1 |
| Blinatumomab | 7 | 42.9 | 43.0 |
| Polatuzumab Vedotin | 6 | 39.2 | 39.3 |
| Irinotecan Hydrochloride | 4 | 19.7 | 19.7 |
| Obinutuzumab | 5 | 19.3 | 19.3 |
| Paliperidone | 7 | 19.2 | 19.2 |
| Ravulizumab | 4 | 18.8 | 18.8 |